These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4682237)

  • 1. Standardization of factor VIII preparations.
    Kasper CK; McDonald JD
    N Engl J Med; 1973 Jan; 288(4):215. PubMed ID: 4682237
    [No Abstract]   [Full Text] [Related]  

  • 2. High purity factor VIII and immune state in HIV.
    Nurs Stand; 1993 Oct 6-12; 8(3):17. PubMed ID: 8217692
    [No Abstract]   [Full Text] [Related]  

  • 3. Doubly virus-inactivated factor VIII concentrate in haemophilia A.
    Chacon JM; Quintana R; Iruin G; Aragües P; Corral J
    Lancet; 1993 Sep; 342(8871):626. PubMed ID: 8102762
    [No Abstract]   [Full Text] [Related]  

  • 4. Prepooled cryoprecipitate for treatment of hemophilia A.
    Menitove JE; Spero JA; Richards WA; Lewis JH; Montgomery RR; Gill JC; Hasiba U; Wheeler DV; Sherwin JA; Russell-Vaskov S; Marlar RA; Maxwell NG; Aster RH
    Transfusion; 1983; 23(3):265-7. PubMed ID: 6407160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory aspects of haemophilia therapy.
    Barrowcliffe TW; Mertens K; Preston FE; Ingerslev J
    Haemophilia; 2002 May; 8(3):244-9. PubMed ID: 12010418
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor VIII preparations: need for prospective pharmacovigilance.
    Vermylen J; Briët E
    Lancet; 1993 Sep; 342(8873):693-4. PubMed ID: 8103816
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor VIII concentrate for hemophilia: comparison of two heat-treated products.
    Walker IR; Pai MK; Blair BA; Johnston MA; Birkett NJ; Ofosu FA; Naylor DH
    CMAJ; 1987 Jan; 136(2):150-2. PubMed ID: 3098401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII concentrate: what is "high purity"?
    Schoppmann A; Weber A; Hondl F; Linnau Y
    Thromb Haemost; 1994 Sep; 72(3):483-4. PubMed ID: 7855803
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
    Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
    Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment with plasma concentrates in hemophilia A. State Security and Health Planning Office. Expert Panel].
    Sangre (Barc); 1994 Apr; 39(2):157-61. PubMed ID: 8059299
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Prowse CV
    Thromb Haemost; 1995 Oct; 74(4):1191-6. PubMed ID: 8560434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?
    Yee TT; Lee CA
    Thromb Haemost; 1999 May; 81(5):852. PubMed ID: 10365768
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.
    Toolis F; McKay G; Prowse CV
    Thromb Haemost; 1980 Feb; 43(1):25-7. PubMed ID: 6773169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of and clinical experience with antihemophilic factor concentrates.
    Johnson AJ; Karpatkin MH; Newman J
    Thromb Diath Haemorrh Suppl; 1968; 35():49-59. PubMed ID: 5317364
    [No Abstract]   [Full Text] [Related]  

  • 15. A survey of one-stage and chromogenic potencies in therapeutic factor VIII concentrates.
    Hubbard AR; Weller LJ; Bevan SA
    Br J Haematol; 2002 Apr; 117(1):247-8. PubMed ID: 11918563
    [No Abstract]   [Full Text] [Related]  

  • 16. France's blood scandal draws blood.
    Nature; 1992 Oct; 359(6398):759. PubMed ID: 1436041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The control and standardization of Factor VIII.
    Aronson DL; Thomas DP
    Scand J Haematol Suppl; 1984; 41():71-8. PubMed ID: 6440287
    [No Abstract]   [Full Text] [Related]  

  • 18. Report of the Subcommittee on Human Factor 8 (AHF) Preparations.
    Wagner RH
    Thromb Diath Haemorrh Suppl; 1967; 26():371-5. PubMed ID: 6064867
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII international units and reference materials.
    Bangham DR; Brozović M
    Thromb Diath Haemorrh; 1974 Mar; 31(1):3-11. PubMed ID: 4836134
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.
    BMJ; 1993 Jan; 306(6873):306-7. PubMed ID: 8461649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.